Pharmacologic characterization of novel adenosine A_2A receptor agonists in equine neutrophils

Medicine & Life Sciences

• Adenosine A2 Receptor Agonists 100%
• Horses 59%
• Neutrophils 48%
• ATL 313 43%
• Purinergic P1 Receptors 25%
• Purinergic P1 Receptor Agonists 20%
• Inhibitory Concentration 50 18%
• Endotoxins 13%
• Reactive Oxygen Species 11%
• Adenosine A3 Receptors 11%
• Adenosine-5'-(N-ethylcarboxamide) 10%
• Anti-Inflammatory Agents 10%
• Purinergic P1 Receptor Antagonists 9%
• Adenosine A2A Receptors 9%
• Adenosine A1 Receptors 9%
• Domestic Animals 8%
• Brain 6%
• Membranes 4%
• Population 2%

Agriculture & Biology

• adenosine 64%
• neutrophils 58%
• agonists 57%
• horses 51%
• receptors 42%
• inhibitory concentration 50 13%
• endotoxins 11%
• anti-inflammatory activity 10%
• reactive oxygen species 8%
• brain 7%
• domestic animals 5%
• selectivity (chemistry) 5%
• antagonists 4%
• assays 2%
• sampling 1%
• cells 1%